Bioceres Crop Solutions (BIOX)
(Real Time Quote from BATS)
$12.10 USD
+0.14 (1.13%)
Updated Apr 23, 2024 11:22 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Bioceres Crop Solutions Corp falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 416 | 335 | 210 | 172 | 160 |
Cost Of Goods | 235 | 208 | 119 | 94 | 87 |
Gross Profit | 180 | 126 | 91 | 79 | 73 |
Selling & Adminstrative & Depr. & Amort Expenses | 126 | 87 | 53 | 40 | 41 |
Income After Depreciation & Amortization | 54 | 40 | 38 | 39 | 32 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 35 | 26 | 28 | 33 | 41 |
Pretax Income | 19 | 14 | 11 | 6 | -9 |
Income Taxes | -1 | 18 | 14 | 2 | 7 |
Minority Interest | 1 | 3 | 3 | 1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 20 | -4 | -4 | 4 | -16 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 19 | -7 | -7 | 3 | -18 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 74 | 49 | 45 | 44 | 37 |
Depreciation & Amortization (Cash Flow) | 19 | 9 | 6 | 5 | 5 |
Income After Depreciation & Amortization | 54 | 40 | 38 | 39 | 32 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 63.19 | 42.30 | 39.22 | 36.42 | NA |
Diluted EPS Before Non-Recurring Items | 0.26 | -0.17 | -0.18 | 0.09 | NA |
Diluted Net EPS (GAAP) | 0.30 | -0.17 | -0.18 | 0.09 | -0.60 |
Fiscal Year end for Bioceres Crop Solutions Corp falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 139.47 | 116.59 | 103.21 | 92.49 |
Cost Of Goods | NA | 88.71 | 71.62 | 64.50 | 36.14 |
Gross Profit | NA | 50.76 | 44.98 | 38.70 | 56.36 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 33.92 | 39.68 | 33.60 | 26.49 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 16.84 | 5.30 | 5.10 | 29.87 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 7.27 | 7.54 | 9.47 | 7.58 |
Pretax Income | NA | 9.57 | -2.25 | -4.37 | 22.29 |
Income Taxes | NA | 8.33 | 0.43 | -1.58 | -5.19 |
Minority Interest | NA | 1.13 | 1.91 | -1.08 | -0.67 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1.24 | -2.68 | -2.79 | 27.48 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.11 | -4.59 | -1.71 | 28.15 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 63.90 | 62.85 | 63.19 | 63.08 |
Diluted EPS Before Non-Recurring Items | NA | 0.00 | -0.07 | -0.06 | 0.45 |
Diluted Net EPS (GAAP) | NA | 0.00 | -0.07 | -0.02 | 0.45 |